ABIVAX Société Anonyme Balance Sheet Health
Financial Health criteria checks 6/6
ABIVAX Société Anonyme has a total shareholder equity of €126.5M and total debt of €111.1M, which brings its debt-to-equity ratio to 87.9%. Its total assets and total liabilities are €284.5M and €158.0M respectively.
Key information
87.9%
Debt to equity ratio
€111.14m
Debt
| Interest coverage ratio | n/a |
| Cash | €222.32m |
| Equity | €126.47m |
| Total liabilities | €158.02m |
| Total assets | €284.49m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0RA9's short term assets (€243.0M) exceed its short term liabilities (€80.0M).
Long Term Liabilities: 0RA9's short term assets (€243.0M) exceed its long term liabilities (€78.1M).
Debt to Equity History and Analysis
Debt Level: 0RA9 has more cash than its total debt.
Reducing Debt: 0RA9's debt to equity ratio has reduced from 104.2% to 87.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0RA9 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 0RA9 has sufficient cash runway for 1.2 years if free cash flow continues to reduce at historical rates of 34.6% each year.